OPL-0101

N/A

Report date: 2023/04/25 09:12:35

Base Information

Drug NameOPL-0101

Drug Alias NameOIL-2OPL-0101CT-101OMCP-mutIL-2

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionNatural killer cells stimulantsCytotoxic T lymphocytes stimulantsInterleukin-2 replacements

TargetsInterleukin-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCourier Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A